Sign in

CIK 0000906709 · Non-accelerated filer<br>Smaller reporting company

NEKTAR THERAPEUTICS

Sign in to watch
Ticker
NKTR
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
943134940
Phone
4154825300
Business address
455 MISSION BAY BOULEVARD SOUTH, SAN FRANCISCO, CA, 94158
Former names
INHALE THERAPEUTIC SYSTEMS INC, INHALE THERAPEUTIC SYSTEMS
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$43,476
in 2 filings

Net −$43,476. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2019-05-22 ROBIN HOWARD W President & CEO Option exercise +33,334 $7.21 $240K 328,660
2019-05-22 ROBIN HOWARD W President & CEO Sale −33,334 $33.38 $1.1M 295,326
2019-05-22 ROBIN HOWARD W President & CEO Option exercise · Common Stock −33,334 33,333
2019-05-21 ROBIN HOWARD W President & CEO Option exercise +33,333 $7.21 $240K 328,659
2019-05-21 ROBIN HOWARD W President & CEO Sale −33,333 $32.93 $1.1M 295,326
2019-05-21 ROBIN HOWARD W President & CEO Option exercise · Common Stock −33,333 66,667
2019-05-16 Thomsen Jillian B. SVP & Chief Accounting Officer Sale −1,928 $31.37 $60K 164,463
2019-05-16 ROBIN HOWARD W President & CEO Sale −13,383 $31.37 $420K 295,326
2019-05-16 Nicholson John SVP & Chief Operating Officer Sale −4,077 $31.37 $128K 166,578
2019-05-16 Labrucherie Gil M SVP & Chief Financial Officer Sale −3,767 $31.37 $118K 127,935
2019-05-16 Hora Maninder SVP Pharma Dev & Mfg Ops Sale −2,449 $31.37 $77K 94,694
2019-05-16 Doberstein Stephen K SVP & Chief Scientific Officer Sale −3,461 $31.37 $109K 95,913
2019-03-08 GREER R SCOTT Director Option exercise +10,000 $5.14 $51K 145,083
2019-03-08 GREER R SCOTT Director Option exercise · Stock Option −10,000 0
2019-02-21 ROBIN HOWARD W President & CEO Option exercise +33,333 $7.21 $240K 342,042
2019-02-21 ROBIN HOWARD W President & CEO Sale −33,333 $41.01 $1.4M 308,709
2019-02-21 ROBIN HOWARD W President & CEO Option exercise · Common Stock −33,333 100,000
2019-02-20 ROBIN HOWARD W President & CEO Option exercise +33,334 $7.21 $240K 342,043
2019-02-20 ROBIN HOWARD W President & CEO Sale −33,334 $43.20 $1.4M 308,709
2019-02-20 ROBIN HOWARD W President & CEO Option exercise · Common Stock −33,334 133,333

Page 26 of 29 · 562 trades